University of California, Irvine

Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought

UCI, OC Health Care Agency lead state’s first study to widely test representative sample of residents

Newswise — Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent.

Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

UCI researchers led the actOC project in partnership with the OC Health Care Agency, which provided funding, testing sites and input on the study’s survey methods and scripts.

Study results appear on the pre-print server site medRxiv: https://www.medrxiv.org/content/10.1101/2020.10.07.20208660v1

“This rigorously designed surveillance study offers important information about how many residents of Orange County have already been exposed to COVID-19,” said Bernadette Boden-Albala, director of UCI’s Program in Public Health and founding dean of the campus’s proposed School of Population Health. “Additionally, the study helps us to understand the impact of disparities.”

The results will enable leaders of the sixth-largest county in the U.S. to identify key demographics at higher risk of contracting – and having adverse outcomes from – the virus.

“The greater prevalence of a positive antibody response among Latinx populations is consistent with some of the testing and hospital data that has come out of Orange County and nationwide,” said Boden-Albala, a co-principal investigator on the study. “As we look toward the fall and flu season, this data also justifies enhanced planning and resources in communities likely to be hit hardest.”

“COVID-19 has had different impacts on different communities across our county. There has been particular concern for communities of color and residents with lower incomes that are disproportionately affected by this virus in terms of infection rates and poorer outcomes. Health equity continues to be paramount, and this study not only confirms the observable trend but also helps inform our strategies and policy recommendations moving forward to help ensure that all of our Orange County neighbors are able to attain access to testing, information and education, as well as the resources they need to care for themselves and their families,” said Dr. Clayton Chau, County Health Officer and director of the OC Health Care Agency.

A groundbreaking process

Working with marketing firm LRW Group to recruit a truly representative sample of Orange County residents, the study enrolled nearly 3,000 random people via phone and email. The participants provided demographic information, revealed whether they had experienced any coronavirus symptoms, and were asked if they’d be willing to undergo blood screening for antibodies.

Those who agreed visited one of 11 drive-thru testing sites – selected based on OC Health Care Agency emergency plans – where medically trained volunteers, primarily UCI students and alumni, collected blood samples using finger pinpricks.

With a UCI-developed imaging platform, the researchers looked for antibody responses to a wide array of respiratory viruses – including SARS-CoV-2, which causes COVID-19. The highly sensitive technology allowed them to identify whether participants had contracted COVID-19 specifically, while many other antibody tests cannot accurately distinguish between it and other coronaviruses. The results were then analyzed and paired with the demographic data.

Researchers are following up every two weeks for four months with a subset of 200 people who tested positive so that they can see how the immune response changes over time.

Potential impact

UCI researchers initiated the study because they had a hunch that the prevalence of COVID-19 had been underestimated, since individuals with few to no symptoms were rarely tested.

“There was this lurking suspicion that there’s a large fraction of people who have had it that did not know,” said co-principal investigator Tim Bruckner, associate professor of public health. “Either they had symptoms and did not seek care, or they did not have symptoms and had no reason to go.”

Recent surveys in other metropolitan regions of the U.S. suggest that infection rates are higher and death rates lower than previously thought and that rates vary significantly from place to place. The results of the actOC project confirm that nearly seven times as many county residents have contracted COVID-19 as had been believed.

It’s the first study in California to employ both a truly representative sample and tests for a wide array of viral antibodies, producing an accurate picture of the disease’s prevalence in Orange County. The team included OC Health Care Agency partners Dr. Clayton Chau, County Health Officer and Director, and Dr. Matthew Zahn, Medical Director of the OC Health Care Agency’s Communicable Disease Control Division; UCI public health researchers Boden-Albala, Bruckner, Daniel Parker, Scott Bartell, Veronica Vieira and Emily Drum; and UCI School of Medicine researchers Saahir Khan and Philip Felgner.

It is not yet clear what levels of antibodies indicate near- or long-term immunity for people who have had COVID-19, but continued follow-up with those who tested positive will provide further data over time. Although 11.5 percent is still substantially below the minimum of 70 percent of residents who would need to have antibodies in order to achieve herd immunity – and given that one county cannot act as a guide for the country as a whole – many researchers hope that representative antibody testing across the U.S. could help guide reopening and public health decisions.

“Our study demonstrates that while a significant number of O.C. residents were already exposed and developed antibodies to COVID-19, much of the county still remains vulnerable to the virus,” Boden-Albala said. “For researchers, there is a lot more work to be done, such as understanding the protection of COVID antibodies and identifying and addressing notable disparities associated with this virus.”

About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 222 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $5 billion annually to the local economy. For more on UCI, visit www.uci.edu.

About the OC Health Care Agency: The OC Health Care Agency (HCA) is a regional provider, charged with protecting and promoting individual, family and community health through coordination of public and private sector resources. The HCA’s service environment is complex, with 180 different funding sources and over 200 State and Federal mandates. The mandates under which HCA operates require the County of Orange to provide for, or to regulate, certain health services. Some examples of services include food protection, hazardous waste regulation, water quality monitoring and pollution prevention, mental health services, substance use disorder services, preventive health services for the aging, healthcare for incarcerated individuals, communicable disease control, homeless services, immunizations, public health field nursing and public health clinics. For more on the HCA, visit www.ochealthinfo.com.

Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.

 

 

NOTE TO EDITORS: PHOTO AVAILABLE AT
https://news.uci.edu/2020/10/28/antibody-screening-finds-covid-19-nearly-7-times-more-prevalent-in-o-c-than-thought/ 

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
VIDEO
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution
Cedars-Sinai

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged
BMJ

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.


Showing results

110 of 4156

close
2.71064